| Literature DB >> 33852680 |
Francine Lima Fulquini1,2, Cristina Mara Zamarioli1, Bárbara Gadioli1, Luciana Kusumota1, Fernanda Raphael Escobar Gimenes1, Emília Campos de Carvalho1.
Abstract
OBJECTIVE: to evaluate the contribution of an instructional module identifying the number and characteristics of lymph nodes by undergraduate nursing students.Entities:
Mesh:
Year: 2021 PMID: 33852680 PMCID: PMC8040781 DOI: 10.1590/1518-8345.4166.3408
Source DB: PubMed Journal: Rev Lat Am Enfermagem ISSN: 0104-1169
Figure 1Flowchart of inclusion, allocation, follow-up and analysis of the participants, adapted from CONSORT( 25 ). Ribeirão Preto, SP, Brazil, 2016-2017
Identification of the number and characteristics of the lymph nodes, by group, in the different phases of the study (N=68). Ribeirão Preto, SP, Brazil, 2016-2017
| Variable |
|
[ | Total |
|
[ | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initial | Initial | Initial | Final | Final | Final | ||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | ||
|
| |||||||||||||
| 7 | 20.00 | 5 | 15.15 | 12 | 17.65 | 13 | 37.14 | 16 | 48.48 | 29 | 42.65 | ||
|
| |||||||||||||
|
| |||||||||||||
| Lymph node I | 17 | 48.57 | 14 | 42.42 | 31 | 45.59 | 16 | 45.71 | 24 | 72.73 | 40 | 58.82 | |
| Lymph node II | 10 | 28.57 | 10 | 30.30 | 20 | 29.41 | 13 | 37.14 | 22 | 66.67 | 35 | 51.47 | |
| Lymph node III | 2 | 5.71 | 4 | 12.12 | 6 | 8.82 | 3 | 8.57 | 18 | 54.55 | 21 | 30.88 | |
| Lymph node IV | 10 | 28.57 | 9 | 27.27 | 19 | 27.94 | 15 | 42.86 | 25 | 75.76 | 40 | 58.82 | |
| Lymph node IV | 3 | 8.57 | 4 | 12.12 | 7 | 10.29 | 7 | 20.00 | 13 | 39.39 | 20 | 29.41 | |
|
| |||||||||||||
| Lymph node I | 16 | 45.71 | 20 | 60.61 | 36 | 52.94 | 15 | 42.86 | 28 | 84.85 | 43 | 63.24 | |
| Lymph node II | 11 | 31.43 | 10 | 30.30 | 21 | 30.88 | 13 | 37.14 | 23 | 69.70 | 36 | 52.94 | |
| Lymph node III | 15 | 42.86 | 19 | 57.58 | 34 | 50.00 | 22 | 62.86 | 32 | 96.97 | 54 | 79.41 | |
| Lymph node IV | 13 | 37.14 | 13 | 39.39 | 26 | 38.24 | 12 | 34.29 | 27 | 81.82 | 39 | 57.35 | |
| Lymph node IV | 2 | 5.71 | 3 | 9.09 | 5 | 7.35 | 3 | 8.57 | 15 | 45.45 | 18 | 26.47 | |
|
| |||||||||||||
| Lymph node I | 3 | 8.57 | 6 | 18.18 | 9 | 13.24 | 14 | 40.00 | 25 | 75.76 | 39 | 57.35 | |
| Lymph node II | 9 | 25.71 | 6 | 18.18 | 15 | 22.06 | 10 | 28.57 | 27 | 81.82 | 37 | 54.41 | |
| Lymph node III | 9 | 25.71 | 11 | 33.33 | 20 | 29.41 | 9 | 25.71 | 33 | 100.00 | 42 | 61.76 | |
| Lymph node IV | 6 | 17.14 | 3 | 9.09 | 9 | 13.24 | 9 | 25.71 | 23 | 69.70 | 32 | 47.06 | |
| Lymph node IV | 1 | 2.86 | 2 | 6.06 | 3 | 4.41 | 3 | 8.57 | 16 | 48.48 | 19 | 27.94 | |
|
| |||||||||||||
| Lymph node I | 29 | 82.86 | 29 | 87.88 | 58 | 85.29 | 29 | 82.86 | 33 | 100.00 | 62 | 91.18 | |
| Lymph node II | 22 | 62.86 | 25 | 75.76 | 47 | 69.12 | 28 | 80.00 | 30 | 90.91 | 58 | 85.29 | |
| Lymph node III | 28 | 80.00 | 29 | 87.88 | 57 | 83.82 | 30 | 85.71 | 33 | 100.00 | 63 | 92.65 | |
| Lymph node IV | 25 | 71.43 | 26 | 78.79 | 51 | 75.00 | 28 | 80.00 | 31 | 93.94 | 59 | 86.76 | |
| Lymph node IV | 4 | 11.43 | 7 | 21.21 | 11 | 16.18 | 11 | 31.43 | 17 | 51.52 | 28 | 41.18 | |
|
| |||||||||||||
| Lymph node III | 8 | 22.86 | 9 | 27.27 | 17 | 25.00 | 5 | 14.29 | 27 | 81.82 | 32 | 47.06 | |
CG = Control group (n=35);
EG = Experimental group (n=33)
Figure 2Interaction between time (initial and final) and groups (CG and EG) for the identification and characteristics variables (size, consistency, mobility, coalescence and location) of the lymph nodes. Ribeirão Preto, SP, 2016-2017
Linear regression analysis of mixed effects for the characteristics of the lymph node according to the groups (N=68). Ribeirão Preto, SP, Brazil, 2016-2017
| Variables | Estimate | Standard error | z-value | p-value |
|---|---|---|---|---|
|
| ||||
| Intercept | 5.708 | 1.015 | 5.627 | 0.000 |
| Experimental Group | 0.277 | 0.658 | 0.421 | 0.674 |
| Final phase | 1.832 | 0.368 | 4.986 | 0.000 |
| Lymph node II | -3.743 | 0.915 | -4.093 | 0.000 |
| Lymph node III | -1.241 | 0.970 | -1.279 | 0.201 |
| Lymph node IV | -3.242 | 0.912 | -3.556 | 0.000 |
| Lymph node IV | -8.205 | 1.080 | -7.599 | 0.000 |
|
| ||||
| Intercept | -0.985 | 0.619 | -1.592 | 0.112 |
| Experimental Group | 0.346 | 0.806 | 0.429 | 0.668 |
| Final phase | 0.340 | 0.374 | 0.907 | 0.364 |
| Lymph node II | -0.539 | 0.393 | -1.372 | 0.170 |
| Lymph node III | -3.062 | 0.450 | -6.802 | 0.000 |
| Lymph node IV | -0.432 | 0.387 | -1.115 | 0.265 |
| Lymph node IV | 1.008 | 0.702 | 1.435 | 0.151 |
| Experimental Group: Final phase | 2.899 | 0.614 | 4.719 | 0.000 |
|
| ||||
| Intercept | -0.578 | 0.548 | -1.054 | 0.292 |
| Experimental Group | 0.980 | 0.725 | 1.352 | 0.176 |
| Final phase | 0.130 | 0.349 | 0.373 | 0.709 |
| Lymph node II | -0.733 | 0.377 | -1.942 | 0.052 |
| Lymph node III | 0.773 | 0.377 | 2.049 | 0.041 |
| Lymph node IV | -0.435 | 0.371 | -1.172 | 0.241 |
| Lymph node IV | -0.499 | 0.568 | -0.878 | 0.380 |
| Experimental Group: Final Phase | 2.832 | 0.562 | 5.037 | 0.000 |
|
| ||||
| Intercept | -2.784 | 0.565 | -4.926 | 0.000 |
| Experimental Group | 0.663 | 0.657 | 1.009 | 0.313 |
| Final phase | 0.961 | 0.387 | 2.480 | 0.013 |
| Lymph node II | 0.750 | 0.399 | 1.879 | 0.060 |
| Lymph node III | 1.051 | 0.386 | 2.721 | 0.007 |
| Lymph node IV | -0.290 | 0.398 | -0.730 | 0.466 |
| Lymph node IV | 0.190 | 0.566 | 0.336 | 0.737 |
| Experimental Group: Final phase | 3.361 | 0.591 | 5.684 | 0.000 |
|
| ||||
| Intercept | -2.427 | 1.061 | -2.288 | 0.022 |
| Experimental Group | 0.626 | 1.161 | 0.539 | 0.590 |
| Final phase | -1.254 | 0.988 | -1.269 | 0.205 |
| Experimental Group: Final phase | 5.950 | 1.935 | 3.075 | 0.002 |
|
| ||||
| Intercept | 10.146 | 2.382 | 4.260 | 0.000 |
| Experimental Group | 1.492 | 1.753 | 0.851 | 0.395 |
| Final phase | 5.126 | 1.782 | 2.877 | 0.004 |
| Lymph node II | 1.074 | 1.439 | 0.747 | 0.455 |
| Lymph node III | -0.255 | 1.141 | -0.223 | 0.823 |
| Lymph node IV | -0.024 | 1.295 | -0.019 | 0.985 |
| Lymph node IV | -0.495 | 2.288 | -0.217 | 0.829 |
Odds Ratio (OR) parameters by time and group for identification and lymph node characteristics. Ribeirão Preto, SP, Brazil, 2016-2017
| Variable | Contrast | OR | SE[ | z.ratio | LL[ | UL[ | p-value | |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Identification | Initial | EG[ | 1.32 | 0.87 | 0.42 | 0.30 | 5.76 | 1.0000 |
| Final | EG[ | 1.32 | 0.87 | 0.42 | 0.30 | 5.76 | 1.0000 | |
| Consistency | Initial | EG[ | 2.66 | 1.93 | 1.35 | 0.52 | 13.53 | 0.3527 |
| Final | EG[ | 45.26 | 35.65 | 4.84 | 7.74 | 264.54 | 0.0000 | |
| Location | Initial | EG[ | 4.45 | 7.79 | 0.85 | 0.09 | 140.74 | 0.7894 |
| Final | EG[ | 4.45 | 7.79 | 0.85 | 0.09 | 140.74 | 0.7894 | |
| Mobility | Initial | EG[ | 1.94 | 1.28 | 1.01 | 0.45 | 8.47 | 0.6259 |
| Final | EG[ | 55.95 | 37.51 | 6.00 | 12.45 | 251.60 | 0.0000 | |
| Size | Initial | EG[ | 1.41 | 1.14 | 0.43 | 0.24 | 8.58 | 1.0000 |
| Final | EG[ | 25.64 | 21.35 | 3.90 | 3.92 | 160.62 | 0.0002 | |
|
| ||||||||
| Identification | CG[ | Final/Initial | 6.25 | 2.30 | 4.99 | 2.74 | 14.24 | 0.0000 |
| EG[ | Final/Initial | 6.25 | 2.30 | 4.99 | 2.74 | 14.24 | 0.0000 | |
| Consistency | CG[ | Final/Initial | 1.14 | 0.40 | 0.37 | 0.52 | 2.49 | 1.0000 |
| EG[ | Final/Initial | 19.34 | 8.63 | 6.64 | 7.11 | 52.59 | 0.0000 | |
| Location | CG[ | Final/Initial | 168.27 | 299.80 | 2.88 | 3.12 | 13970.20 | 0.0080 |
| EG[ | Final/Initial | 168.27 | 299.80 | 2.88 | 3.12 | 13970.20 | 0.0080 | |
| Mobility | CG[ | Final/Initial | 2.61 | 1.01 | 2.48 | 1.10 | 6.23 | 0.0263 |
| EG[ | Final/Initial | 75.34 | 35.67 | 9.13 | 26.07 | 217.68 | 0.0000 | |
| Size | CG[ | Final/Initial | 1.40 | 0.53 | 0.91 | 0.62 | 3.29 | 0.7285 |
| EG[ | Final/Initial | 25.49 | 12.65 | 6.52 | 8.30 | 76.25 | 0.0000 |
OR = Odds ratio;
SE = Standard error;
LL = Confidence interval lower limit;
UL = Confidence interval upper limit;
EG = Experimental group;
CG = Control group